Evidence-Based Nutrition Strategies for Cardiac Recovery

Cardiovascular disease (CVD) remains the leading cause of mortality globally, accounting for approximately 17.9 million deaths per year according to the World Health Organization. Diet is one of the most modifiable risk factors for both primary prevention and secondary prevention — reducing the risk of a subsequent event after a first MI, stroke, or coronary revascularisation.

The landmark Lyon Diet Heart Study demonstrated that a Mediterranean-style dietary intervention reduced cardiac death and non-fatal MI by 70% over four years compared to a control diet — an effect size that rivals or exceeds most pharmacological interventions studied in comparable populations.

Dietary improvements act through multiple simultaneous mechanisms: reducing LDL cholesterol and triglycerides, lowering blood pressure, decreasing systemic inflammation (measured by CRP and IL-6), improving endothelial function, and supporting a healthier gut microbiome — all independent cardiovascular risk pathways.

The Dietary Approaches to Stop Hypertension (DASH) diet was originally developed to lower blood pressure without medication, but its cardiovascular benefits extend far beyond blood pressure reduction. It consistently reduces LDL cholesterol, total cholesterol, and systemic inflammation markers in controlled trials.

DASH emphasises high intake of fruits, vegetables, low-fat dairy, whole grains, poultry, fish, and nuts while substantially limiting red and processed meat, full-fat dairy, tropical oils, and foods and beverages high in added sugars or sodium. The target sodium intake is 1,500–2,300 mg/day — significantly below most Western dietary patterns.

In the original DASH trial, the diet lowered systolic blood pressure by an average of 11 mmHg in hypertensive participants — comparable to the effect of a single antihypertensive drug — without caloric restriction. The DASH-Sodium trial confirmed that reducing sodium on top of the DASH pattern produces additive BP reductions.

💡 Practical point: The DASH pattern is particularly well-suited for post-MI patients who also have hypertension, type 2 diabetes, or dyslipidaemia — conditions that frequently co-exist and that DASH addresses simultaneously through a single dietary framework.

The Mediterranean diet is characterised by high intake of olive oil, vegetables, legumes, fruits, whole grains, and fish; moderate consumption of poultry and dairy; low intake of red and processed meat; and red wine in moderation with meals (where culturally appropriate and clinically safe).

The PREDIMED trial — a large Spanish randomised controlled trial of 7,447 participants at high cardiovascular risk — found that supplementation with extra-virgin olive oil or mixed nuts within a Mediterranean dietary pattern reduced the primary cardiovascular endpoint by approximately 30% compared to a low-fat control diet. The trial was stopped early due to the magnitude of benefit.

Olive oil, the centrepiece fat of the Mediterranean diet, is rich in oleocanthal (a natural COX inhibitor with anti-inflammatory properties) and oleic acid — a monounsaturated fatty acid that reduces LDL oxidation and supports HDL function. Extra-virgin olive oil specifically retains these polyphenols; refined olive oil does not.

Oily fish — salmon, mackerel, sardines, anchovies, and herring — provide long-chain omega-3 fatty acids (EPA and DHA), which reduce triglycerides, decrease platelet aggregation, stabilise cardiac rhythm, and exert anti-inflammatory effects on vascular endothelium. A target of two or more servings per week is recommended by most cardiac nutrition guidelines.

Saturated and trans fats are the primary dietary drivers of elevated LDL cholesterol. Saturated fat (found in full-fat dairy, fatty cuts of meat, palm oil, and coconut oil) raises LDL by inhibiting LDL receptor activity in the liver. Trans fats (partially hydrogenated oils, still present in some processed foods) both raise LDL and lower HDL — a doubly detrimental effect. Most guidelines recommend limiting saturated fat to <7% of total energy.

Dietary sodium contributes to hypertension — a major independent cardiovascular risk factor — by expanding plasma volume and increasing vascular resistance. The average Western diet provides 3,400–4,000 mg sodium per day, primarily from processed and restaurant foods rather than added table salt. Reducing sodium to <2,300 mg/day (ideally <1,500 mg/day post-MI) is a key dietary modification.

Excess added sugar — particularly in sugary beverages — drives hypertriglyceridaemia, insulin resistance, visceral adiposity, and systemic inflammation, all of which elevate cardiovascular risk independently of LDL. The American Heart Association recommends no more than 25 g (6 tsp) of added sugar per day for women and 36 g (9 tsp) for men.

Ultra-processed foods (UPFs) — industrially manufactured products with multiple additives, emulsifiers, and refined ingredients — have been consistently associated in large prospective cohorts with increased risk of heart disease, stroke, and cardiovascular mortality, independent of nutrient content. Minimising UPFs as a category is now explicitly recommended by several national dietary guidelines.

The plate method is an accessible visual framework for cardiac-appropriate meals: fill half the plate with non-starchy vegetables, one quarter with lean protein (fish, legumes, skinless poultry), and one quarter with high-fibre complex carbohydrates (whole grains, sweet potato, legumes). Add a thumb-sized portion of healthy fat (avocado, olive oil, nuts).

Meal preparation strategies are as important as food choices. Cooking methods matter significantly — grilling, steaming, baking, poaching, and stir-frying in olive oil preserve nutritional quality and minimise added saturated fat, compared to deep frying or heavy cream-based sauces.

Reading nutrition labels is a critical skill for cardiac patients. Patients should be taught to check: serving size (the basis for all listed values), sodium per serving, saturated and trans fat, and the ingredients list (where trans fats appear as 'partially hydrogenated oils' and added sugars under many names including sucrose, high-fructose corn syrup, dextrose, and maltose).

Alcohol warrants explicit discussion with post-MI patients. While low-to-moderate consumption has been associated with some cardiovascular benefit in observational studies, the evidence is methodologically contested, and alcohol is contraindicated with many cardiac medications including warfarin, certain antiarrhythmics, and statins (potentiating myopathy risk). No specific alcohol intake should be 'recommended' for cardiovascular benefit.